Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Immune protection is dependent on the gut microbiome in a lethal mouse gammaherpesviral infection.

Yaron JR, Ambadapadi S, Zhang L, Chavan RN, Tibbetts SA, Keinan S, Varsani A, Maldonado J, Kraberger S, Tafoya AM, Bullard WL, Kilbourne J, Stern-Harbutte A, Krajmalnik-Brown R, Munk BH, Koppang EO, Lim ES, Lucas AR.

Sci Rep. 2020 Feb 11;10(1):2371. doi: 10.1038/s41598-020-59269-9.

2.

Myxomavirus-derived serpin prolongs survival and reduces inflammation and hemorrhage in an unrelated lethal mouse viral infection.

Chen H, Zheng D, Abbott J, Liu L, Bartee MY, Long M, Davids J, Williams J, Feldmann H, Strong J, Grau KR, Tibbetts S, Macaulay C, McFadden G, Thoburn R, Lomas DA, Spinale FG, Virgin HW, Lucas A.

Antimicrob Agents Chemother. 2013 Sep;57(9):4114-27. doi: 10.1128/AAC.02594-12. Epub 2013 Jun 17.

3.

Mouse Gamma Herpesvirus MHV-68 Induces Severe Gastrointestinal (GI) Dilatation in Interferon Gamma Receptor-Deficient Mice (IFNγR-/-) That Is Blocked by Interleukin-10.

Chen H, Bartee MY, Yaron JR, Liu L, Zhang L, Zheng D, Hogue IB, Bullard WL, Tibbetts S, Lucas AR.

Viruses. 2018 Sep 23;10(10). pii: E518. doi: 10.3390/v10100518.

4.

Reactive Center Loop (RCL) Peptides Derived from Serpins Display Independent Coagulation and Immune Modulating Activities.

Ambadapadi S, Munuswamy-Ramanujam G, Zheng D, Sullivan C, Dai E, Morshed S, McFadden B, Feldman E, Pinard M, McKenna R, Tibbetts S, Lucas A.

J Biol Chem. 2016 Feb 5;291(6):2874-87. doi: 10.1074/jbc.M115.704841. Epub 2015 Nov 30.

5.

Murine gammaherpesvirus targets type I IFN receptor but not type III IFN receptor early in infection.

Lopušná K, Benkóczka T, Lupták J, Matúšková R, Lukáčiková Ľ, Ovečková I, Režuchová I.

Cytokine. 2016 Jul;83:158-170. doi: 10.1016/j.cyto.2016.04.013. Epub 2016 May 3.

PMID:
27152708
6.

MDA5 Is Critical to Host Defense during Infection with Murine Coronavirus.

Zalinger ZB, Elliott R, Rose KM, Weiss SR.

J Virol. 2015 Dec;89(24):12330-40. doi: 10.1128/JVI.01470-15. Epub 2015 Sep 30.

7.

Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection.

Dutia BM, Allen DJ, Dyson H, Nash AA.

Virology. 1999 Sep 1;261(2):173-9.

8.

Protective and pathologic roles of the immune response to mouse hepatitis virus type 1: implications for severe acute respiratory syndrome.

Khanolkar A, Hartwig SM, Haag BA, Meyerholz DK, Epping LL, Haring JS, Varga SM, Harty JT.

J Virol. 2009 Sep;83(18):9258-72. doi: 10.1128/JVI.00355-09. Epub 2009 Jul 1.

9.

Murine gammaherpesvirus 68 encoding open reading frame 11 targets TANK binding kinase 1 to negatively regulate the host type I interferon response.

Kang HR, Cheong WC, Park JE, Ryu S, Cho HJ, Youn H, Ahn JH, Song MJ.

J Virol. 2014 Jun;88(12):6832-46. doi: 10.1128/JVI.03460-13. Epub 2014 Apr 2.

10.

Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease.

Walsh KB, Edwards RA, Romero KM, Kotlajich MV, Stohlman SA, Lane TE.

J Immunol. 2007 Jul 15;179(2):1155-65.

11.

T cell epitope specificity and pathogenesis of mouse hepatitis virus-1-induced disease in susceptible and resistant hosts.

Khanolkar A, Fulton RB, Epping LL, Pham NL, Tifrea D, Varga SM, Harty JT.

J Immunol. 2010 Jul 15;185(2):1132-41. doi: 10.4049/jimmunol.0902749. Epub 2010 Jun 16.

12.

Pathogenesis of mouse hepatitis virus infection in gamma interferon-deficient mice is modulated by co-infection with Helicobacter hepaticus.

Compton SR, Ball-Goodrich LJ, Zeiss CJ, Johnson LK, Johnson EA, Macy JD.

Comp Med. 2003 Apr;53(2):197-206.

PMID:
12784855
13.
14.

Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence?

Aligo J, Walker M, Bugelski P, Weinstock D.

J Immunotoxicol. 2015 Jan-Mar;12(1):1-15. doi: 10.3109/1547691X.2014.882996. Epub 2014 Feb 10. Review.

PMID:
24512328
15.

Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model.

El-Gogo S, Staib C, Meyr M, Erfle V, Sutter G, Adler H.

Vaccine. 2007 May 16;25(20):3934-45. Epub 2007 Mar 6.

PMID:
17433507
16.

Analysis of a novel strain of murine gammaherpesvirus reveals a genomic locus important for acute pathogenesis.

Macrae AI, Dutia BM, Milligan S, Brownstein DG, Allen DJ, Mistrikova J, Davison AJ, Nash AA, Stewart JP.

J Virol. 2001 Jun;75(11):5315-27.

17.

Interleukin 1α-Deficient Mice Have an Altered Gut Microbiota Leading to Protection from Dextran Sodium Sulfate-Induced Colitis.

Nunberg M, Werbner N, Neuman H, Bersudsky M, Braiman A, Ben-Shoshan M, Ben Izhak M, Louzoun Y, Apte RN, Voronov E, Koren O.

mSystems. 2018 May 8;3(3). pii: e00213-17. doi: 10.1128/mSystems.00213-17. eCollection 2018 May-Jun.

18.

CD8+ T Cell Response to Gammaherpesvirus Infection Mediates Inflammation and Fibrosis in Interferon Gamma Receptor-Deficient Mice.

O'Flaherty BM, Matar CG, Wakeman BS, Garcia A, Wilke CA, Courtney CL, Moore BB, Speck SH.

PLoS One. 2015 Aug 28;10(8):e0135719. doi: 10.1371/journal.pone.0135719. eCollection 2015.

19.

Mouse hepatitis virus neurovirulence: evidence of a linkage between S glycoprotein expression and immunopathology.

Rempel JD, Murray SJ, Meisner J, Buchmeier MJ.

Virology. 2004 Jan 5;318(1):45-54.

20.

Myxomavirus anti-inflammatory chemokine binding protein reduces the increased plaque growth induced by chronic Porphyromonas gingivalis oral infection after balloon angioplasty aortic injury in mice.

Lucas AR, Verma RK, Dai E, Liu L, Chen H, Kesavalu S, Rivera M, Velsko I, Ambadapadi S, Chukkapalli S, Kesavalu L.

PLoS One. 2014 Oct 29;9(10):e111353. doi: 10.1371/journal.pone.0111353. eCollection 2014.

Supplemental Content

Support Center